Skip to content
10-Q

Quarterly Report

ESTRELLA IMMUNOPHARMA, INC. ESLA ESLAW

0001213900-25-074567

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 37.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 36.17M sh
Shares Diluted Q2 2025 · Jun 30, 2025 36.18M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.38M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.18M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$880.86K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.53M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.32M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $916.92K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$6.09M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$1.83M
Stockholders Equity Q2 2025 · Dec 31, 2024 $143.73K
Stockholders Equity Q2 2025 · Jun 30, 2024 $4.27M
Stockholders Equity Q2 2025 · Mar 31, 2024 $8.49M
Stockholders Equity Q2 2025 · Dec 31, 2023 $9.05M
Current Liabilities Q2 2025 · Jun 30, 2025 $9.08M
Current Liabilities Q2 2025 · Dec 31, 2024 $3M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.08M
Total Liabilities Q2 2025 · Dec 31, 2024 $3M
Current Assets Q2 2025 · Jun 30, 2025 $1.48M
Current Assets Q2 2025 · Dec 31, 2024 $1.64M
Total Assets Q2 2025 · Jun 30, 2025 $2.98M
Total Assets Q2 2025 · Dec 31, 2024 $3.14M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.12
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.11
Eps Basic Q2 2025 · Jun 30, 2024 −$0.12
Sga Expense Q2 2025 · Jun 30, 2025 $883.73K
Sga Expense Q2 2025 · Jun 30, 2025 $1.58M
Sga Expense Q2 2025 · Jun 30, 2024 $424.45K
Sga Expense Q2 2025 · Jun 30, 2024 $868.98K
Rd Expense Q2 2025 · Jun 30, 2025 $4.66M
Rd Expense Q2 2025 · Jun 30, 2025 $6.07M
Rd Expense Q2 2025 · Jun 30, 2024 $3.53M
Rd Expense Q2 2025 · Jun 30, 2024 $3.55M
Net Income Q2 2025 · Jun 30, 2025 −$5.54M
Net Income Q2 2025 · Jun 30, 2025 −$7.65M
Net Income Q2 2025 · Mar 31, 2025 −$2.1M
Net Income Q2 2025 · Jun 30, 2024 −$3.95M
Net Income Q2 2025 · Jun 30, 2024 −$4.42M
Net Income Q2 2025 · Mar 31, 2024 −$469.53K
Operating Income Q2 2025 · Jun 30, 2025 −$5.54M
Operating Income Q2 2025 · Jun 30, 2025 −$7.65M
Operating Income Q2 2025 · Jun 30, 2024 −$3.95M
Operating Income Q2 2025 · Jun 30, 2024 −$4.42M
Stock Repurchased Q2 2025 · Jan 30, 2024 $1M